Antibodies and the Immune Memory

Antibodies are proteins produced by plasma cells that bind specifically to antigens, neutralising pathogens or marking them for destruction. Immune memory ensures a faster, stronger response upon re-exposure to the same pathogen. This lesson covers antibody structure, function, classes, and the mechanism of immune memory for the Edexcel A-Level Biology (9BI0) specification.

---

Structure of an Antibody

Antibodies (also called immunoglobulins, abbreviated Ig) are Y-shaped glycoproteins produced by plasma cells (differentiated B cells).

Basic Structure

Each antibody molecule consists of:

Component	Description
2 heavy chains	Longer polypeptide chains forming the stem and part of the arms of the Y
2 light chains	Shorter polypeptide chains forming the rest of the arms
Disulphide bonds	Hold the chains together and maintain the 3D shape
Hinge region	Flexible area allowing the two arms to move independently and bind to antigens at different distances apart
Variable region	The tips of the Y arms; unique to each antibody; forms the antigen-binding site
Constant region	The stem and lower arms; same within each antibody class; determines the antibody's function (effector function)

The Antigen-Binding Site

• Each antibody has two identical antigen-binding sites (one on each arm).
• The shape of the binding site is complementary to the shape of the specific antigen (like a lock and key).
• This complementarity is determined by the variable regions of the heavy and light chains.
• The diversity of antibodies is generated by gene rearrangement (V(D)J recombination) during B cell development, allowing the immune system to produce antibodies against virtually any antigen.

Exam Tip: The variable region determines specificity (which antigen the antibody binds to). The constant region determines function (what the antibody does once it has bound). Always use precise terminology.

---

Functions of Antibodies

Antibodies do not directly kill pathogens. Instead, they neutralise or mark them for destruction by other components of the immune system.

Function	Mechanism	Detail
Neutralisation	Antibodies bind to pathogen surface proteins, blocking their ability to attach to and infect host cells	E.g. antibodies bind to viral glycoprotein spikes, preventing the virus from attaching to host cell receptors
Agglutination	Antibodies (especially IgM) cross-link multiple pathogens, clumping them together	Clumps are too large for pathogens to spread and are easily phagocytosed
Opsonisation	Antibodies coat the pathogen surface, making it easier for phagocytes to recognise and engulf	The Fc region of the antibody binds to Fc receptors on phagocytes
Complement activation	Antibody-antigen complexes activate the complement system, leading to MAC formation and lysis	Particularly effective against bacterial cells
Toxin neutralisation	Antibodies (called antitoxins) bind to toxins, preventing them from damaging host cells	E.g. antibodies against diphtheria or tetanus toxin
Precipitation	Antibodies bind to soluble antigens, forming insoluble complexes that precipitate out of solution	Removed by phagocytes

---

Classes of Antibodies (Immunoglobulins)

There are five major classes of antibodies, each with a distinct structure and function:

Class	Structure	Location	Function
IgG	Monomer (single Y)	Blood, tissue fluid; crosses the placenta	Most abundant; long-lasting immunity; opsonisation; complement activation; passed to foetus
IgM	Pentamer (5 Y-units joined)	Blood	First antibody produced in primary response; very effective at agglutination
IgA	Dimer (2 Y-units)	Mucous membranes, saliva, tears, breast milk	Protects mucosal surfaces; passed to infant via breast milk
IgE	Monomer	Bound to mast cells and basophils	Triggers histamine release; involved in allergic reactions and defence against parasites
IgD	Monomer	Surface of naive B cells	Functions as a B cell receptor (BCR); involved in B cell activation

Exam Tip: You are most likely to be asked about IgG and IgM. IgM is the first antibody class produced (large pentamer, effective at agglutination). IgG is the most abundant and long-lasting, and is the only class that crosses the placenta (providing passive immunity to the foetus).

---

Immune Memory

One of the most important features of the adaptive immune system is its ability to "remember" pathogens. This is mediated by memory cells.

How Memory Works

1. During the primary immune response, activated B and T cells produce effector cells (plasma cells, cytotoxic T cells) and memory cells.
2. Effector cells are short-lived — they die once the infection is cleared.
3. Memory cells are long-lived — they persist in the body for years or even a lifetime.
4. Upon re-exposure to the same antigen, memory cells are activated rapidly (within hours), undergo clonal expansion, and produce a large number of effector cells.
5. This secondary immune response is:
   • Faster (1–3 days vs 7–14 days)
   • Stronger (higher antibody concentration)
   • Longer-lasting (higher sustained levels of antibodies)

Comparison of Primary and Secondary Responses

Feature	Primary	Secondary
Response time	7–14 days	1–3 days
Peak antibody level	Lower	Much higher
Duration of response	Shorter	Longer
Main cell type	Naive lymphocytes	Memory lymphocytes
Main antibody class	IgM (then IgG)	IgG

---

Active and Passive Immunity

Type	How acquired	Memory produced?	Duration	Example
Active natural	Infection by the pathogen	Yes	Long-term	Catching measles and recovering
Active artificial	Vaccination	Yes	Long-term (may need boosters)	MMR vaccine
Passive natural	Antibodies transferred from mother to foetus (via placenta) or infant (via breast milk)	No	Short-term (weeks to months)	IgG across placenta; IgA in breast milk
Passive artificial	Injection of antibodies (antiserum) from another individual or animal	No	Short-term	Anti-venom; anti-tetanus immunoglobulin

Exam Tip: Active immunity involves the individual's own immune system producing antibodies and memory cells. Passive immunity involves receiving pre-formed antibodies from an external source. Only active immunity produces memory and long-term protection.

---

Monoclonal Antibodies

Monoclonal antibodies are identical antibodies produced by a single clone of B cells. They are used in medicine and research because of their specificity.

Production

1. A mouse is injected with the target antigen.
2. B cells are isolated from the mouse's spleen.
3. B cells are fused with myeloma cells (cancerous B cells that divide indefinitely) to form hybridoma cells.
4. Hybridoma cells are screened for the desired antibody production.
5. The selected hybridoma is cultured to produce large quantities of identical antibodies.

Applications

Application	Detail
Pregnancy testing	Monoclonal antibodies against hCG (human chorionic gonadotrophin) on test strips
Medical diagnosis	ELISA tests for HIV, COVID-19 lateral flow tests
Cancer treatment	Therapeutic antibodies target specific antigens on cancer cells (e.g. Herceptin targets HER2 on breast cancer cells)
Research	Used to identify and locate specific proteins in tissues (immunohistochemistry)

---

Key Terms

Term	Definition
Antibody	A Y-shaped glycoprotein produced by plasma cells that binds specifically to an antigen
Variable region	The part of the antibody that determines antigen-binding specificity
Constant region	The part of the antibody that determines its class and effector function
Agglutination	Clumping of pathogens by cross-linking with antibodies
Opsonisation	Coating a pathogen with antibodies to enhance phagocytosis
Immune memory	The ability of the immune system to respond more rapidly and strongly to a previously encountered antigen
Monoclonal antibody	An antibody produced by a single clone of B cells; highly specific to one antigen

---

Summary

• Antibodies are Y-shaped proteins with variable regions (specificity) and constant regions (function).
• They neutralise pathogens, cause agglutination, enhance opsonisation, and activate complement.
• IgM is the first antibody produced; IgG is the most abundant and crosses the placenta.
• Immune memory is mediated by long-lived memory B and T cells.
• The secondary response is faster, stronger, and longer-lasting than the primary response.
• Monoclonal antibodies are used in diagnosis, treatment, and research.

---

A-Level Deep Dive: Antibodies and the Immune Memory

Spec mapping

The Edexcel 9BI0 specification places antibodies and immunological memory squarely within Topic 6: Immunity, Infection and Forensics, downstream of B-cell and T-cell biology. Lesson 7 (B and T cells) ended with plasma-cell differentiation and the primary/secondary distinction — this lesson unpacks what plasma cells secrete and how memory operates molecularly. Lesson 9 (vaccination) is the direct application: every vaccine exploits the memory-cell substrate established here. Synoptic links extend to Topic 1 (antibody quaternary structure: two heavy + two light chains held by disulfide bonds, hinge region, Fab/Fc split, variable-region paratope) and Topic 8 (V(D)J recombination as the somatic gene-rearrangement source of antibody diversity). HIV-driven destruction of CD4$^+$+ T helpers blocks class switching from IgM to IgG, the clinical demonstration that antibody maturation depends on T-helper cytokine licensing. Relevant statements concern antibody structure, the four mechanisms of action (opsonisation, agglutination, neutralisation, complement activation), antibody classes, primary/secondary curves, immunological memory and the active/passive distinction (refer to the official Pearson Edexcel 9BI0 specification document for exact wording).

---

Worked example with full mark scheme

Question (8 marks):

A child cuts their hand on a contaminated surface and acquires a Streptococcus pyogenes infection. Within seven days serum IgM is detectable; by day fourteen the dominant class is IgG. Phagocytes engulf the bacteria far more efficiently after antibody production begins.

(a) Trace the molecular events from antigen recognition by a B-cell receptor through to circulating IgG, naming the cytokines and the molecular event that converts IgM into IgG. (4)

(b) Explain how circulating antibodies enhance bacterial clearance, identifying four distinct effector mechanisms by which antibodies act on S. pyogenes. (4)

Solution with mark scheme:

(a) Stage 1 — antigen recognition. A naive B cell whose BCR (membrane-bound IgM/IgD) binds an S. pyogenes surface antigen (e.g. M-protein), internalises it, processes it lysosomally and re-displays peptide on MHC class II.

M1 (AO1.1) — BCR engagement, endocytosis, MHC II re-display.

Stage 2 — linked recognition with T helper. A previously activated CD4$^+$+ T helper with a matching TCR binds the peptide–MHC II complex; CD40L–CD40 co-stimulation plus cytokines (IL-4, IL-5, IL-6) drive clonal expansion.

M1 (AO1.2) — linked recognition; CD40L + IL-4/5/6 licensing.

Stage 3 — plasma-cell differentiation and IgM secretion. Daughter cells differentiate into plasma cells secreting pentameric IgM (~2,000 molecules/sec) — the early, low-affinity, high-avidity response.

M1 (AO2.1) — plasma cells secrete pentameric IgM early.

Stage 4 — class switching to IgG. In germinal centres, isotype class switching (directed DNA recombination at the heavy-chain constant-region locus) replaces C$_\mu$μ​ with C$_\gamma$γ​ — V-region specificity preserved, effector function swapped. IL-4 drives switching to IgG; IL-5 to IgA; IL-4 + IL-13 to IgE.

A1 (AO3.1a) — class switching as DNA recombination, V-region preserved, cytokine-directed isotype choice.

(b) M1 (AO1.2) — Opsonisation. Antibody Fab binds the bacterial surface; the Fc region is recognised by Fc$\gamma$γ receptors on neutrophils and macrophages, increasing phagocytosis efficiency.

M1 (AO1.2) — Agglutination. Multivalent cross-linking (two Fab on IgG, ten on the IgM pentamer) clumps bacteria into aggregates that cannot disseminate and are easily phagocytosed.

M1 (AO2.1) — Complement activation (classical pathway). Antibody–antigen complexes recruit C1q, triggering C1 → C4/C2 → C3 cleavage → C5b–C9 MAC; C3b further opsonises and C3a/C5a recruit phagocytes.

A1 (AO3.1a) — Neutralisation. Antibodies bind toxin active sites or pathogen attachment proteins, blocking host-cell entry. S. pyogenes streptolysin is neutralised this way; for viral pathogens, antibody-blocked spike proteins prevent receptor engagement.

Total: 8 marks.

---

Specimen question modelled on the Edexcel 9BI0 paper format

Question (6 marks): Compare the primary and secondary humoral responses, and explain how the molecular and cellular differences between them account for the protective effect of vaccination.

Mark scheme decomposition by AO:

Marking point	AO	Credit-worthy content
1	AO1.1	States the primary response has a ~7–14 day lag, low peak titre and is dominated by IgM (pentameric, low affinity, high avidity) before IgG transition. The naive pool must be searched for a rare matching clone (~1 in $10^6$106) which then undergoes ~10–15 rounds of mitosis.
2	AO1.2	States the secondary response has a ~1–2 day lag, much higher peak titre, dominated by class-switched IgG, with higher affinity from germinal-centre somatic hypermutation. Memory clones are pre-expanded and skip the rate-limiting search.
3	AO2.1	Explains the cellular substrate: memory B cells are antigen-experienced (BCR class-switched and affinity-matured), longer-lived and at higher precursor frequency than naive cells. Memory T helpers license them faster on re-exposure.
4	AO2.1	Explains class switching as directed DNA recombination at the heavy-chain constant-region locus, swapping C$_\mu$μ​ for C$_\gamma$γ​ (or C$_\alpha$α​, C$_\epsilon$ϵ​), preserving V-region specificity while changing effector function. T-helper cytokines direct isotype choice (IL-4 → IgG; IL-5 → IgA; IL-4 + IL-13 → IgE).
5	AO3.1a	Connects the curves to vaccination: a vaccine delivers antigen in non-pathogenic form (attenuated, inactivated, subunit, conjugate, mRNA), driving APC presentation, T-helper activation and the first response — so field encounter triggers the second (rapid, IgG-dominated, high-affinity) response that clears the pathogen before symptoms.
6	AO3.2a	Concludes that vaccination's protective effect is not biochemical "training" — it is pre-paying the rate-limiting clonal-selection step. The intrinsic memory architecture supplies the protection; the vaccine substitutes a safe priming antigen for a dangerous one.

Total: 6 marks (AO1 = 2, AO2 = 2, AO3 = 2). Specimen question modelled on the Edexcel 9BI0 paper format.

---

Synoptic links